Uploaded October 2026 | Updated November 2026, 4 days ago
After 23 years on the same statistical computing environment, Novartis moved its study teams to a new cloud-based SCE called Quanta. In the change readiness assessment, the lowest score was 4.7 out of 5.
In this conversation, Anna De Feo, Change Management Director at Novartis, talks with Marcin Dubel, Head of Technology at Appsilon, about how they got there and what it means for AI adoption in a regulated environment.
What you’ll learn:
- The CCT model: why Novartis puts change, communication and training under one umbrella from day one
- How Quanta Bot, an AI assistant built on version-controlled documentation, supports users after rollout and hands off to human experts when it doesn’t know the answer
- How to measure adoption with dashboards, the “no more than three clicks” rule and readiness assessments
- Why local end-to-end design teams keep adoption going after the global rollout ends
- How to bring AI-assisted and open source programming into teams that rely on validated SAS macros
This session continues the change management roundtable from the Validated AI for Pharma Summit. Watch the full Summit here: appsilon.com/validated-ai-for-pharma-summit
Learn more about Appsilon: appsilon.com
#Pharma #ChangeManagement #AIAdoption #ClinicalDevelopment #ValidatedAI
After 23 years on the same statistical computing environment, Novartis moved its study teams to a new cloud-based SCE called Quanta. In the change readiness assessment, the lowest score was 4.7 out of 5.
In this conversation, Anna De Feo, Change Management Director at Novartis, talks with Marcin Dubel, Head of Technology at Appsilon, about how they got there and what it means for AI adoption in a regulated environment.
What you’ll learn:
- The CCT model: why Novartis puts change, communication and training under one umbrella from day one
- How Quanta Bot, an AI assistant built on version-controlled documentation, supports users after rollout and hands off to human experts when it doesn’t know the answer
- How to measure adoption with dashboards, the “no more than three clicks” rule and readiness assessments
- Why local end-to-end design teams keep adoption going after the global rollout ends
- How to bring AI-assisted and open source programming into teams that rely on validated SAS macros
This session continues the change management roundtable from the Validated AI for Pharma Summit. Watch the full Summit here: appsilon.com/validated-ai-for-pharma-summit
Learn more about Appsilon: appsilon.com
#Pharma #ChangeManagement #AIAdoption #ClinicalDevelopment #ValidatedAI










